Snowball logo
logo
CALT_logo

Calliditas Therapeutics

SEK 208.00SEK 0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
184.80.874229.3802.91,206.91,601.4
COGS
---15.277.06104.7
Gross Profit
184.80.874229.3787.71,129.81,496.7
Operating Expenses & Income
Operating Income
(28.02)(379.7)(524.5)(421.9)(384.4)(368.2)
Total Operating Expenses
212.7383.1753.81,209.61,514.21,864.9
R&D Expenses
149.8241.4357.5414.7499.5557.9
Selling General & Admin Expenses
62.88102.8210.6259.5333452.1
Earnings from Continuing Operations
Interest Expense
(0.325)(0.393)(7.108)(12.53)(73.2)(115.2)
Interest Income
0.92656.4311.0812.5329.094.509
Income Tax Expense
0.0770.36(3.836)2.8519.16812.04
Net Income
Net Income
(32.58)(436.5)(509.5)(412.3)(466.2)(480.4)
Supplemental
EBIT
(26.95)(381.7)(558.9)(434.9)(384.4)(370.8)
EBITDA
(25.13)(378.9)(524.5)(421.9)(367.8)(365.5)
In millions of SEK, except % and values per 1 share